Marion Webb has been writing about health care issues for nearly two decades as a full-time reporter and freelancer. As the senior business reporter for the San Diego Business Journal, Marion covered new medical innovations at San Diego’s top-ranking research institutions and the medical device and life sciences industry for nearly eight years. She’s also been a regular contributor to the Los Angeles County Medical Association’s Physician Magazine and Physicians News Network focusing on new technologies, practice management, reimbursement and other trendy issues relevant to physician practices and their ability to succeed. She remains fascinated by the ever-growing numbers of innovative products coming out of the medtech sector, from potentially life-saving devices to help treat patients who otherwise wouldn’t have access to medical care to breakthrough technologies that benefit mankind. Marion earned her BA in communications from UC San Diego and continues to enjoy an active lifestyle in San Diego.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Marion Webb
Stryker launched the Mako robotic arm-assisted total knee arthroplasty system at last week's AAOS annual meeting, making the company the first to offer a surgical robotic technology that covers the total knee, partial knee and total hip replacements. Critics, however, say the clinical outcomes do not necessarily justify the costs. Meanwhile, Stryker's orthopedic rivals, Zimmer Biomet and Smith & Nephew, also sought to highlight their own robotic offerings.
Neocis, an emerging company founded by an Mako Surgical alumni, has won US FDA clearance for its Yomi robotic guidance system, the first of its kind to assist dentists with dental implant procedures. The system is unique in that it offers surgeons both physical and visual guidance and the flexibility to change a preset plan during surgery.
From "smart" snake-like catheters to miniscule-sized devices, a new generation of surgical robots, developed at world-renowned research institutions, aims to explore a new frontier by allowing doctors to target inaccessible areas within the body, and treat conditions with greater precision and better patient outcomes. With the surgical robotics market projected to surpass $10bn by 2021, a growing number of companies are hoping to capture their share in this trending space.
The global market for osteoporosis diagnostic products is expected to expand from $253m in 2015 to $304m by 2020, fueled by a rising aging population and the need to test for osteoporosis and associated fracture risk. This article offers an in-depth look at the growth markets for both bone densitometer testing and biochemical marker tests, as well as the evolving competitive landscape, and the drivers and barriers to market entry.
The $1bn in cash and stock deal will create a pure-play infusion therapy company with estimated revenue of about $1.45bn.
Advocacy groups for diagnostic services to test for osteoporosis scored a big win when the US Centers for Medicare and Medicaid Services agreed to raise Medicare reimbursement rates for DXA bone density scans in the hospital setting this year rather than cutting the rates as initially proposed. However, there is not such good news for doctors providing in-office DXA scans, as they struggle with continuing declining reimbursement rates that cannot offset the costs of the procedures.